semaglutide and covid vaccine proves effective against obesity, Novartis' Sandoz buys three antibiotics from GSK GLP-1 Agonists Medications - Medical

Tirzepatide: 20.2% in SURMOUNT-5 In the head-to-head SURMOUNT-5 trial, tirzepatide reached 20.2% average weight loss compared with 13.7% for semaglutide at 72 weeks

Topiramate can slightly increase the risk for kidney stones, therefore optimized liquid intake should be recommended to patients

Am J Physiol Endocrinol Metab 305:E243253 Du Y, Carranza Z, Luan Y, Busman-Sahay K, Wolf S, Campbell SP, Kim SY, Pejovic T, Estes JD, Zelinski M et al (2022) Evidence of cancer therapy-induced chronic inflammation in the ovary across multiple species: a potential cause of persistent tissue damage and follicle depletion

mexicana -infected mice, the expression of IL-4 still remained elevated in skin lesions as seen by scRNA-seq (Fig